About: AKI during COVID-19 infection: low incidence, high risk of death

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: AKI during COVID-19 infection: low incidence, high risk of death Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	AKI during COVID-19 infection: low incidence, high risk of death
Creator	Zhang, Xu Med, M Mou, Zhixiang
Source	MedRxiv
abstract	Background: Coronavirus disease 2019 (COVID-19) has spread rapidly worldwide and seriously threatens human health since December 2019. However, information about acute kidney injury (AKI) during COVID-19 infection is limited. Some studies thought that presence of AKI is very common and cannot be ignored, while some studies pointed that AKI only is a rare incident during COVID-19 infection. This meta-analysis aimed to find out the truth of COVID-19 related AKI and to provide stronger evidence. Methods: Two authors independently performed a literature search using PubMed, Web of Science, Embase, and Cochrane Library fulfilled the pre-specified criteria until April 25, 2020 to include studies reported the necessary clinic characteristics, then the incidence of AKI, incidence of required RRT, the mortality with AKI and the death risk with AKI during COVID-19 infection were pooled for statistical analysis by Open Meta-Analyst software to get conclusions. Findings: It was found that the incidence of AKI in hospitalized patients with COVID-19 infection is low, only about 3.8%; the in-hospital mortality with AKI in COVID-19 infected patients is reach up to 32.6%; the death risk with AKI in COVID-19 infected patients is about 16.1 times higher than those without AKI. Conclusions: This meta-analysis indicated AKI during COVID-19 infection should be pay more attention, it maybe a strong red flag to death risk. It is still need additional studies to support the conclusions and to explore the AKI mechanism during COVID-19 infection.
has issue date	2020-05-04(xsd:dateTime)
bibo:doi	10.1101/2020.04.29.20079038
has license	medrxiv
sha1sum (hex)	a0aefbe28a2f036d977d34afb4d9d490d10b58a2
schema:url	https://doi.org/10.1101/2020.04.29.20079038
resource representing a document's title	AKI during COVID-19 infection: low incidence, high risk of death
resource representing a document's body	covid:a0aefbe28a2f036d977d34afb4d9d490d10b58a2#body_text
is schema:about of	named entity 'AKI' named entity 'POINTED' named entity 'studies' named entity 'worldwide' named entity 'COVID-19' named entity 'Coronavirus disease 2019' named entity 'meta-analysis' named entity 'Some' named entity 'acute kidney injury' named entity 'human health' named entity 'COVID' named entity 'Acute respiratory distress syndrome' named entity 'kidney' named entity 'Redmond, WA' named entity 'AKI' named entity 'preprint' named entity 'ACE2' named entity 'AKI' named entity 'PROSPERO' named entity 'meta-analysis' named entity 'COVID' named entity 'COVID' named entity 'COVID' named entity 'medRxiv' named entity 'CC-BY 4.0 International license' named entity 'COVID' named entity 'cough' named entity 'kidney' named entity 'AKI' named entity 'COVID' named entity 'preprint' named entity 'SARS-CoV-2' named entity 'AKI' named entity 'kidney' named entity 'severe acute respiratory syndrome coronavirus 2' named entity 'AKI' named entity 'CC-BY 4.0 International license' named entity 'CC-BY 4.0 International license' named entity 'CC-BY 4.0 International license' named entity 'infection' named entity 'infection' named entity 'AKI' named entity 'organ dysfunction' named entity 'COVID' named entity 'Brown University' named entity 'podocytes' named entity 'critical illness' named entity 'organ' named entity 'COVID' named entity 'COVID' named entity 'coronavirus 2019' named entity 'Systematic Reviews' named entity 'AKI' named entity 'meta-analysis' named entity 'AKI' named entity 'renal replacement therapy' named entity 'COVID-19 infection' named entity 'Statistically significant' named entity 'Web of Science' named entity 'RRT' named entity 'medRxiv' named entity 'preprint' named entity 'Windows 10' named entity 'COVID' named entity 'AKI' named entity 'AKI' named entity 'pulmonary hypertension' named entity 'nCoV' named entity 'Meta-Analyses' named entity 'acute kidney injury' named entity 'COVID' named entity 'infection' named entity 'medRxiv' named entity 'Epidemiological data' named entity 'AKI' named entity 'AKI' named entity 'community-acquired pneumonia' named entity 'medRxiv' named entity 'COVID' named entity 'CC-BY 4.0 International license' named entity 'preprint' named entity 'preprint' named entity 'CC-BY 4.0 International license'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software